Choline Kinase, A Novel Drug Target for the Inhibition of Streptococcus pneumoniae
Gram-positive pathogens, such as Streptococcus pneumoniae, can have deleterious effects on both human and animal health. Antibiotics and antimicrobials have been developed to treat infections caused by such pathogens and to prevent food contamination. However, these strategies have been increasingly...
Saved in:
Main Authors: | Tahl Zimmerman (Author), Salam Ibrahim (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quercetin Is a Novel Inhibitor of the Choline Kinase of <i>Streptococcus pneumoniae</i>
by: Tahl Zimmerman, et al.
Published: (2022) -
Parallel Colorimetric Quantification of Choline and Phosphocholine as a Method for Studying Choline Kinase Activity in Complex Mixtures
by: Tahl Zimmerman, et al.
Published: (2018) -
Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases
by: Juan Carlos Lacal, et al.
Published: (2021) -
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials
by: Beatriz Maestro, et al.
Published: (2016) -
Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019
by: Ning Wang, et al.
Published: (2021)